Communication courte
Pancreatic Cancer Remains a Deadly Disease. Why?
Examen d'experts
Clinicopathologic Features and Therapeutic Strategies of this Tumor of the Pancreas
Commentaire
Current Treatment Strategy for Intraductal Papillary Mucinous Neoplasms (IPMNs)
Hypothèse
Clinical Presentations of Rare Pancreatic Neuroendocrine Neoplasms (panNENs)
Article original
Does Erlotinib Restore Chemosensitivity to Chemotherapy in Pancreatic Cancer? A Retrospective Analysis
Does stenting of pancreaticojejunostomy after pancreatico-duodenectomy mitigate expected complication - Evaluation of a prospective observational study.